Tech Company Financing Transactions

OpGen Funding Round

OpGen closed a $17 million venture capital round on 3/7/2012. Investors included CHL Medical Partners, Cross Creek Capital and Harris & Harris Group.

Transaction Overview

Company Name
OpGen
Announced On
3/7/2012
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Undisclosed
Investors

CHL Medical Partners (Ronald Lennox)

Cross Creek Capital

Harris & Harris Group (Misti Ushio)

Highland Capital Partners (Bijan Salehizadeh)

jVen Capital (Evan Jones)

Versant Ventures (Brian Atwood)

Proceeds Purpose
The proceeds from this financing will be used to accelerate the commercialization of OpGen's Argus Whole Genome Mapping System as well as its Genome-Builder tool suite for large genome sequencing assembly and data analysis.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
708 Quince Orchard Rd.
Gaithersburg, MD 20878
USA
Phone
(301) 869-9683
Website
www.opgen.com
Email Address
[email protected]
Overview
OpGen (NASDAQ: OPGN) is a leading provider of genetic analysis services and systems. The company's proprietary Optical Mapping system (see technology) is used by academic and commercial organizations worldwide for applications including comparative genomics and genome sequence assembly/validation.
Profile
OpGen LinkedIn Company Profile
Social Media
OpGen Company Twitter Account
Company News
OpGen News
Facebook
OpGen on Facebook
YouTube
OpGen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Oliver Schacht
  Oliver Schacht LinkedIn Profile  Oliver Schacht Twitter Account  Oliver Schacht News  Oliver Schacht on Facebook
Chief Financial Officer
Timothy Dec
  Timothy Dec LinkedIn Profile  Timothy Dec Twitter Account  Timothy Dec News  Timothy Dec on Facebook
Chief Marketing Officer
Faranak Atrzadeh
  Faranak Atrzadeh LinkedIn Profile  Faranak Atrzadeh Twitter Account  Faranak Atrzadeh News  Faranak Atrzadeh on Facebook
Chief Operating Officer
Johannes Bacher
  Johannes Bacher LinkedIn Profile  Johannes Bacher Twitter Account  Johannes Bacher News  Johannes Bacher on Facebook
VP - Bus. Development
Chris Emery
  Chris Emery LinkedIn Profile  Chris Emery Twitter Account  Chris Emery News  Chris Emery on Facebook
VP - Regulatory Affairs
Autumn Collasius
  Autumn Collasius LinkedIn Profile  Autumn Collasius Twitter Account  Autumn Collasius News  Autumn Collasius on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/7/2012: WallitApp venture capital transaction
Next: 3/7/2012: Dollar Shave Club venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.